Advertisements


Iovance Biotherapeutics reports results from FDA end of Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Sierra Oncology Reports First Quarter 2019 Results

Momelotinib regulatory pathway clarity anticipated in Q2 2019 -- SRA737 Phase 1/2 preliminary clinical data anticipated at the 2019 ASCO Annual Meeting - VANCOUVER, May 8, 2019 /PRNewswire/ - Sierra Oncology, Inc. ("Sierra Oncology") (NASDAQ:.....»»

Category: earningsSource: benzingaMay 8th, 2019

Loxo Oncology Reports First Quarter 2018 Financial Results

- LOXO-292 Phase 1 Oral Presentation Upcoming at 2018 ASCO Annual Meeting - - LOXO-292 Preclinical and Cl.....»»

Category: earningsSource: benzingaMay 8th, 2018

Cerus reports results of SPARC Phase 3 study at EHA meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Aclaris Therapeutics reports "positive" results from Phase 2 trial of ATI-502

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2019

Calithera Biosciences reports "positive" results from Phase 2 ENTRATA study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2019

Mallinckrodt Presents Encouraging Data on Acthar Gel for RA

Mallinckrodt (MNK) reports encouraging results from a phase IV study on Acthar for RA at the EUL.....»»

Category: dealsSource: nytJun 14th, 2019

Concert Pharmaceuticals reports results from two Phase 1 CTP-692 studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Dr. Reddy"s Reports Positive Top-Line Data on Psoriasis Drug

Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate.....»»

Category: worldSource: nytJun 10th, 2019

Dynavax reports results from Phase 1b/2 study of SD-101 and Keytruda combination

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

Arianne Phosphate Reports Corporate and Financial Results for First Quarter 2019 and Announces Election Results of its 2019 Annual General Meeting

DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGU.....»»

Category: earningsSource: benzingaMay 29th, 2019

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»

Category: earningsSource: benzingaMay 24th, 2019

Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update

Top-line results from Phase III Epsolay® and TWIN trials remain on track; mid-2019 and 4Q19, respectfully Reports top-line generic product revenues of $6.3 million NESS ZIONA, Israel, May 22.....»»

Category: earningsSource: benzingaMay 22nd, 2019

Achillion reports interim Phase 2 PNH trial data at PNH meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2019

Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward

Shares of small-cap biotech Iovance Biotherapeutics Inc (NASDAQ: IOVA) were making a strong upward move Thursday on more than 10 times their average volume.  read more.....»»

Category: blogSource: benzingaMay 16th, 2019

AstraZeneca to present results from Phase III POLO trial at ASCO meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2019

Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress

Enrollment for Phase 1b Tria.....»»

Category: earningsSource: benzingaMay 15th, 2019

resTORbio Reports First Quarter 2019 Financial Results and Corporate Update

Initiated first Phase 3 trial, PROTECTOR 1, of RTB101 in clinically symptomatic respiratory illness; top-line data from two pivotal Phase 3 trials expected in mid-2020 Initiated Phase 1b/2a trial .....»»

Category: earningsSource: benzingaMay 15th, 2019

Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update

Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in.....»»

Category: earningsSource: benzingaMay 15th, 2019

Aptevo Therapeutics Reports First Quarter 2019 Financial Results

Achieves 73% Increase in First Quarter 2019 Year-Over-Year IXINITY® Net Revenue On Target for Launch of New 3,000 IU IXINITY Assay Mid-2019 Advances Enrollment in APVO436 and APVO210 Phase 1 Clinical Studies; An.....»»

Category: earningsSource: benzingaMay 9th, 2019

ObsEva Reports First Quarter 2019 Financial Results

  2019 Phase 3 Data Readouts on.....»»

Category: earningsSource: benzingaMay 9th, 2019